Aussteller & Produkte auf MEDICA & COMPAMED

therapy is a cancer treatment that induces cancer cell death by heat generated in tumor tissue exposed to near-infrared light. FluoGuide’s FG001 has...the potential to act as a near-infrared light absorbent to facilitate efficient and cancer cell targeted heat destruction. Photothermal therapy is...excitation brings FG001 to an excitation state where it releases energy in the form of heat. Under optimal conditions, the generated heat will kill cancer

Patient Monitoring for Epileptic Drugs, Antibiotics and Cancer Immunosupressions.

rapid tests including markers of fertility, infectious diseases, drug of abuse, tumor markers and cancer markers based on lateral flow

tool for personalized monitoring of cancer patients of all types of solid tumors.

aggressiveness of cancer. These unique characteristics make uPAR-targeting an outstanding solution to help guide surgeons in removing cancerous tissue. By creating...allow cancer to spread. uPAR is extensively expressed on the surface of most types of solid cancers, and its concentration directly correlates to the...pancreatic cancers, making the platform relevant for surgeries in at least three million patients each year. The path forward for FluoGuide’s products is...FluoGuide A/S is a clinical stage biotechnology company focused on developing drugs for maximizing surgical outcomes by making cancer fluorescent....are designed to increase surgical precision by making cancer cells fluorescent during surgery. FG001 has been demonstrated to be safe and well-tolerated...and has been shown, in an ongoing proof-of-concept phase IIa clinical trial, to make aggressive brain cancer fluorescent in patients undergoing surgery....extracellular matrix. In other words, uPAR is part of a cell-bound enzyme system present on the invasive forefront of cancer where it degrades normal tissue to...fluorescence in cancer cells during surgery, FluoGuide’s products can help surgeons differentiate cancer from normal tissue during surgery and thereby...photothermal treatments that induce cancer cell death by heat generated by the fluorophobic part of the products. FG001 has in pre-clinical trials been...demonstrated to remove cancer tissue when it is heated by being exposed to near-infrared light. The improved precision in surgical oncology offered by

screening, follow-up care and therapeutic decisions in cancer diagnostics. GynTect - test for reliable detection of cervical cancer and its precancerous...precancerous lesions. CE IVD marked since 2022, aiming at the screening market. OroTect - test in development for the detection of head and neck cancer (...lesions. CE IVD marked since 2016, NMPA approved for China since 2022! ScreenYu Gyn  - test for reliable detection of cervical cancer and its...tonsil, oropharynx, larynx, ...  cancer )! The oncgnostics GmbH is specialist for the development of methylation based diagnostics, several projects

an automated software component to analyze, interpret, and report the generated data. Oncobit’s products provide a detailed understanding of genomic cancer...Oncobit’s approach is data-centric, modular, and expandable to other cancer types in the future and can be easily adapted for use as companion diagnostics.

HORIZON-MISS-2021-CANCER-02-01 "Entwicklung neuer Methoden und Technologien für die Krebsvorsorge und Früherkennung" (Projekt: MammoScreen; dies wird UBT die Möglichkeit

BMA-Produkte werden in unseren eigenen Produktionsstätten hergestellt, und in Korea wurde ihre Qualität anerkannt und an das National Cancer Center